NPI: 1205112539 · CARTHAGE, MS 39051 · Medicare Defined Swing Bed Hospital Unit · NPI assigned 11/01/2011
Authorized official DUCKETT, GREGORY controls 20+ related entities in our dataset. Read more
| Authorized Official | DUCKETT, GREGORY (SR VP/ CLO) |
| Parent Organization | BAPTIST MEMORIAL HEALTH CARE CORP. |
| NPI Enumeration Date | 11/01/2011 |
Other providers sharing the same authorized official: DUCKETT, GREGORY
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 29,667 | $1.16M |
| 2019 | 32,282 | $1.24M |
| 2020 | 25,824 | $949K |
| 2021 | 34,046 | $1.20M |
| 2022 | 53,813 | $1.43M |
| 2023 | 34,034 | $1.26M |
| 2024 | 23,538 | $1.02M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 15,131 | 11,831 | $1.56M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 9,557 | 7,346 | $1.33M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5,274 | 4,145 | $949K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 5,926 | 4,795 | $424K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 4,824 | 927 | $391K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 4,536 | 3,493 | $350K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 6,946 | 5,045 | $242K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 5,033 | 4,165 | $215K |
| 70450 | Computed tomography, head or brain; without contrast material | 2,855 | 2,288 | $213K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 6,470 | 5,055 | $212K |
| 71045 | Radiologic examination, chest; single view | 5,918 | 4,472 | $202K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 879 | 699 | $178K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2,246 | 1,677 | $168K |
| 71046 | Radiologic examination, chest; 2 views | 3,652 | 2,964 | $160K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1,873 | 1,197 | $154K |
| 96361 | Intravenous infusion, hydration; each additional hour | 2,218 | 1,259 | $135K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 10,598 | 4,201 | $132K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 7,280 | 5,358 | $129K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 722 | 586 | $105K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 19,934 | 14,695 | $104K |
| 80053 | Comprehensive metabolic panel | 12,721 | 9,693 | $100K |
| 96375 | Therapeutic injection; each additional sequential IV push | 3,183 | 2,352 | $74K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 5,503 | 4,207 | $73K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1,357 | 1,235 | $46K |
| 83880 | 2,398 | 1,810 | $44K | |
| 74018 | 973 | 744 | $44K | |
| G0378 | Hospital observation service, per hour | 241 | 155 | $43K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1,691 | 1,325 | $39K |
| 80048 | Basic metabolic panel (calcium, ionized) | 6,682 | 4,935 | $35K |
| 84484 | 5,733 | 3,501 | $34K | |
| 36415 | Collection of venous blood by venipuncture | 16,414 | 11,500 | $34K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1,803 | 1,614 | $28K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 1,919 | 1,512 | $26K |
| 84443 | Thyroid stimulating hormone (TSH) | 1,481 | 1,236 | $21K |
| 73560 | 512 | 398 | $21K | |
| 80061 | Lipid panel | 1,738 | 1,535 | $20K |
| 81001 | 8,435 | 6,551 | $18K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 2,014 | 1,737 | $14K |
| 81025 | 2,400 | 1,946 | $14K | |
| 80305 | 1,316 | 1,121 | $12K | |
| 87807 | 1,074 | 904 | $11K | |
| 73630 | 273 | 217 | $11K | |
| 83690 | 2,365 | 1,853 | $11K | |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | 26 | 25 | $10K |
| 82553 | 853 | 656 | $9K | |
| A9270 | Non-covered item or service | 2,446 | 1,587 | $7K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 70 | 54 | $6K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 38 | 35 | $6K |
| 83735 | 1,770 | 1,286 | $6K | |
| 83605 | 1,127 | 718 | $5K | |
| 73030 | 129 | 106 | $5K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 53 | 40 | $5K |
| 82550 | 925 | 722 | $5K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1,025 | 774 | $5K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 16 | 13 | $5K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 70 | 69 | $4K |
| 87040 | 629 | 278 | $4K | |
| J7030 | Infusion, normal saline solution , 1000 cc | 3,102 | 2,090 | $4K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 3,420 | 2,675 | $4K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 13 | 13 | $4K |
| 87186 | 768 | 401 | $3K | |
| 82150 | 544 | 465 | $3K | |
| 73610 | 66 | 50 | $3K | |
| 85379 | 396 | 333 | $3K | |
| 84702 | 132 | 110 | $2K | |
| 85610 | 987 | 754 | $2K | |
| 99233 | Prolong inpt eval add15 m | 157 | 67 | $2K |
| 87400 | 86 | 69 | $2K | |
| 87210 | 603 | 530 | $2K | |
| 85027 | 396 | 284 | $2K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | 200 | 81 | $2K |
| 73130 | 34 | 27 | $2K | |
| 86308 | 209 | 191 | $2K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 13 | 12 | $1K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 25 | 12 | $1K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 2,527 | 1,902 | $1K |
| 74019 | 15 | 12 | $1K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 23 | 13 | $1K |
| 87430 | 64 | 56 | $936.36 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 44 | 43 | $916.36 |
| 96376 | 69 | 36 | $879.97 | |
| 82803 | 26 | 24 | $768.57 | |
| 83874 | 46 | 35 | $599.70 | |
| 73110 | 13 | 12 | $578.32 | |
| 73502 | 20 | 14 | $531.76 | |
| 86900 | 24 | 12 | $525.00 | |
| 87077 | 92 | 49 | $458.31 | |
| 85730 | 130 | 78 | $417.76 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 2,120 | 1,619 | $342.92 |
| 86850 | 24 | 12 | $233.04 | |
| 99238 | Hospital discharge day management, 30 minutes or less | 21 | 17 | $221.39 |
| 86140 | 94 | 58 | $214.45 | |
| 87070 | 29 | 24 | $192.41 | |
| 36600 | 12 | 12 | $174.66 | |
| 86901 | 24 | 12 | $158.70 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 1,394 | 1,071 | $136.86 |
| 87205 | 28 | 24 | $134.53 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 109 | 67 | $133.07 |
| 87147 | 49 | 13 | $106.54 | |
| 84550 | 32 | 26 | $103.06 | |
| 80076 | 18 | 17 | $95.55 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 196 | 115 | $93.36 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 773 | 609 | $87.76 |
| 84703 | 20 | 14 | $71.75 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 225 | 155 | $33.55 |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 32 | 28 | $29.35 |
| J1940 | Injection, furosemide, up to 20 mg | 94 | 62 | $20.42 |
| 36416 | 14 | 12 | $16.80 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | 220 | 162 | $15.96 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 24 | 21 | $4.86 |
| C9113 | Injection, pantoprazole sodium, per vial | 16 | 13 | $3.85 |
| J7510 | Prednisolone oral, per 5 mg | 36 | 30 | $1.13 |
| 93320 | 26 | 25 | $0.00 | |
| 93325 | 26 | 25 | $0.00 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 12 | 12 | $0.00 |
| 84145 | 17 | 14 | $0.00 |